What does a modified-Fibonacci dose-escalation actually correspond to?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Health Informatics,Epidemiology
Link
http://link.springer.com/article/10.1186/1471-2288-12-103/fulltext.html
Reference11 articles.
1. Rogatko A, Schoeneck D, Jonas W, Tighiouart M, Khuri FR, Porter A: Translation of innovative designs into phase I trials. J Clin Oncol. 2005, 25: 4982-6.
2. Ratain MJ, Mick R, Schilsky RL, Siegler M: Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents. J Natl Cancer Inst. 1993, 85: 1637-43. 10.1093/jnci/85.20.1637.
3. Storer BE: Choosing a phase I design. Handbook of statistics in Clinical Oncology. Edited by: Crowley J, Hoering A, Ankerst D. 2005, Chapman & Hall/CRC Press, Taylor and Francis Group LLC, 600 Broken Parkway, NW, Suie 300, Boca Raton, FL, 59-Third edition April 2012, Second Edition
4. Omura GA: Modified Fibonacci search. J Clin Oncol. 2003, 21: 3177-79. 10.1200/JCO.2003.99.058.
5. Omura GA: Phase 1 Dose-finding trials and Fibonacci. Clin Cancer Research. 2006, 12: 321-10.1158/1078-0432.CCR-05-1762.
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The 3 + 3 design in dose-finding studies with small sample sizes: Pitfalls and possible remedies;Clinical Trials;2024-04-15
2. A phase I study of Hemay022, an irreversible dual EGFR/HER2 tyrosine kinase inhibitor in Chinese patients with HER2-positive advanced breast cancer;Chinese Journal of Cancer Research;2024
3. Early Intravenous Beta-Blockade with Esmolol in Adults with Severe Traumatic Brain Injury (EBB-TBI): Protocol for a Phase 2a Intervention Design Study;Neurocritical Care;2023-06-12
4. Early intravenous Beta-Blockade with esmolol in adults with isolated severe Traumatic Brain Injury (EBB-TBI): protocol for a phase 2a intervention design study;2023-03-01
5. Experimental Medicine Approaches in Early-Phase CNS Drug Development;Advances in Neurobiology;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3